We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors in Mirum Pharmaceuticals Inc (Symbol: MIRM) saw new options become available this week, for the March 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

NASDAQ MIRM opened at $47.53 on Friday. The company has a 50-day simple moving average of $43.70 and a two-hundred day simple moving average of $41.45. Mirum Pharmaceuticals has a 12-month low of ...

Mirum Pharmaceuticals, Inc. (MIRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...